Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
The Ras Gene02:38

The Ras Gene

7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.0K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The fission yeast β-arrestin-like protein Any1 is involved in TSC-Rheb signaling and the regulation of amino acid transporters.

Journal of cell science·2013
Same author

Microtubules and Alp7-Alp14 (TACC-TOG) reposition chromosomes before meiotic segregation.

Nature cell biology·2013
Same author

Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2.

Oxidative medicine and cellular longevity·2013
Same author

Proper microtubule structure is vital for timely progression through meiosis in fission yeast.

PloS one·2013
Same author

Transforming growth factor-β induces transcription factors MafK and Bach1 to suppress expression of the heme oxygenase-1 gene.

The Journal of biological chemistry·2013
Same author

A mouse model of adult-onset anaemia due to erythropoietin deficiency.

Nature communications·2013

Related Experiment Videos

Contribution of GATA1 dysfunction to multi-step leukemogenesis.

Ritsuko Shimizu1, Masayuki Yamamoto

  • 1Department of Molecular Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Cancer Science
|September 4, 2012
PubMed
Summary

GATA1 gene dysfunction, crucial for blood cell development, is linked to leukemia. Mutations in GATA1 cause immature cell accumulation, driving leukemogenesis in various blood disorders.

Related Experiment Videos

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Hematopoietic homeostasis relies on balanced stem cell functions and gene expression.
  • GATA1 is a key transcription factor for erythroid and megakaryocytic cell development.
  • Dysregulation of GATA1 is implicated in various hematopoietic disorders.

Purpose of the Study:

  • To review multi-step leukemogenesis.
  • To focus on the role of GATA1 dysfunction in leukemia development.

Main Methods:

  • Literature review of studies on GATA1 function and hematopoietic disorders.
  • Analysis of genetic mutations affecting GATA1 and their impact on cell development.
  • Examination of the role of GATA1 dysregulation in leukemogenesis.

Main Results:

  • Somatic mutations in GATA1 lead to truncated proteins, contributing to transient myeloproliferative disorder and acute megakaryoblastic leukemia in Down syndrome infants.
  • Mutations in GATA1 regulatory regions reduce its expression, implicated in murine erythroid leukemia.
  • GATA1 dysregulation results in the accumulation of immature progenitor cells, a key factor in leukemia pathogenesis.

Conclusions:

  • GATA1 dysfunction is a critical driver of leukemogenesis.
  • Understanding GATA1's role is essential for comprehending and potentially treating hematopoietic disorders like leukemia.